Delores L. Galias, RN, RHIT
STATEMENT OF CONFIDENTIALITY:
The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and may contain confidential or privileged information. If you are not the intended recipient, please notify D. Galias, RN, RHIT immediately at [EMAIL PROTECTED] and destroy all copies of this message and any attachments. Thank you for your cooperation
--- Begin Message ---Item Type: Appointment Start Date: 05/21/2004 09:00 am Eastern Daylight Time (Friday) Duration: 2 Hours Place: Hubert H. Humphrey Bldg., Room 800The Department of Health and Human Services will host a listening session on Friday, May 21st to solicit input on research priorities under Medicare Reform Legislation signed by President Bush in December 2003. Section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) authorizes research, demonstrations, and evaluations to improve the quality, effectiveness, and efficiency of the Federally-administered Medicare program and two programs for which funding and administration is shared with the States: Medicaid and the State Children's Health Insurance Program (SCHIP). The research and other activities undertaken and authorized by this provision may address: 1. The outcomes, comparative clinical effectiveness, and appropriateness of health care items and services (including Prescription drugs) 2 Strategies for improving the efficiency and effectiveness of such programs, including the ways in which such items and services are organized, managed, and delivered under such programs. The statute: a. Requires the establishment of a priority setting process for identifying the most important topics to address b. Establishes a timetable for development of an initial priority list and completion of the research c. Requires ongoing consultation with relevant stakeholders. The new law requires the initial priority list for research to be developed by June 2004 and initial research to be completed in December 2005. To review the text of Section 1013 of the MMA, please visit the "Research on Outcomes of Health Care Items and Services" website at http://www.medicare.gov/MedicareReform/108s1013.pdf Participants in the listening session are asked to focus their comments on: 1) suggested topics for study under Section 1013 2) structure of the priority lists (e.g., disease/condition, type of intervention, effected population, etc.). 3) methods to answer these questions of safety and effectiveness as quickly and efficiently as possible. Date: May 21, 2004 Time: 9:00 a.m. to 11:00 a.m. (EDT) Place: Hubert H. Humphrey Building Room 800 - The John M. Eisenberg Room 200 Independence Ave., SW Washington, D.C. 20201 Map & Directions: http://www.hhs.gov/about/hhhmap.html (Federal Center SW metro station) An audio line has been established for anyone not able to attend the meeting in person: Dial-in#: 877-546-1565 and password is "Medicare Listening Session" Submission of Comments and RSVPs: Participants may provide oral or written comments. Oral comments are limited to three minutes and may be given in person or via telephone. All written comments, RSVPs to attend and/or to speak at this listening session are required to be sent to [EMAIL PROTECTED] no later than May 18, 2004. More information will be coming soon. We look forward to your participation. Thank you.
--- End Message ---
